Oral Pazopanib Results in Durable Hemostasis in Patients with Severe Bleeding and RBC Transfusion-dependent Hereditary Hemorrhagic Telangiectasia

On Tuesday, July 20, 2021, Hanny Al-Samkari, M.D., of Massachusetts General Hospital in Boston presented results on oral pazopanib for severe hereditary hemorrhagic telangiectasia (HHT)-associated bleeding.

Nanomedicine Targeting to Activated Neutrophils and Neutrophil-Platelet Complexes Provides Effective Thromboprotection

On Monday, July 19, 2021, Dillon Bohinc of Case Western Reserve University School of Medicine in Cleveland presented results from research aimed at developing a therapeutic strategy that specifically targets activated, pathogenic neutrophil subsets without the ubiquitous inhibition of resting cells.

CRISPR Edited Megakaryocytes for Rapid Screening of Platelet Gene Functions

Emilie Montenont, Ph.D., of The University of Utah commented that the goal of her research was to develop and define the strengths and limitations of a rapid and systematic approach to screen genes for platelet functions in primary megakaryocytes called CRIMSON.